HEM-9

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHEM-9
Drug Alias Namehemophilia B gene therapy (Copernicus)HEM-9
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCopernicus Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCopernicus Therapeutics
Active IndicationsN/A
Inactive IndicationsHemophilia B

Other Information

ATC CodeN/A
Related LinksN/A